Abstract
No public abstract is available from the verified source records.
Carlos Eduardo Rochitte, Adriano Camargo de Castro Carneiro
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies
10.1161/01.cir.93.5.841 · 1996
Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document
10.1161/circheartfailure.120.007405 · 2020
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European society of cardiology working group on myocardial and pericardial diseases
10.1093/eurheartj/eht210 · 2013
Myocarditis
10.1056/nejmra2114478 · 2022
10.1016/j.jacc.2007.09.008
10.1016/j.jacc.2007.09.008 · 2007
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
10.1093/eurheartj/ehi258 · 2005
International consensus group on cardiovascular magnetic resonance in myocarditis. cardiovascular magnetic resonance in myocarditis: a JACC white paper
10.1016/j.jacc.2009.02.007 · 2009
Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations
10.1016/j.jacc.2018.09.072 · 2018
Cardiovascular magnetic resonance imaging for inflammatory heart diseases
10.21037/cdt.2019.12.09 · 2020
Brazilian society of cardiology guideline on myocarditis - 2022
10.36660/abc.20220412 · 2022
2023 ESC guidelines for the management of cardiomyopathies
10.1093/eurheartj/ehad194 · 2023
Trends in the incidence of in-hospital mortality, cardiogenic shock, and utilization of mechanical circulatory support devices in myocarditis (analysis of national inpatient sample data, 2005-2014)
10.1016/j.cardfail.2019.04.012 · 2019
2023 ESC guidelines for the management of acute coronary syndromes
10.1093/eurheartj/ehad191 · 2023
Multiparametric cardiac magnetic resonance imaging in pediatric and adolescent patients with acute myocarditis
10.1007/s00247-021-05169-7 · 2021
Comparison of original and 2018 Lake Louise Criteria for diagnosis of acute myocarditis: results of a validation cohort
10.1148/ryct.2019190010 · 2019
Feature tracking myocardial strain incrementally improves prognostication in myocarditis beyond traditional CMR imaging features
10.1016/j.jcmg.2020.04.025 · 2020
Diagnostic implications of magnetic resonance feature tracking derived myocardial strain parameters in acute myocarditis
10.1016/j.ejrad.2015.11.023 · 2016
Feature tracking-derived peak systolic strain compared to late gadolinium enhancement in troponin-positive myocarditis: a case-control study
10.1007/s00246-015-1333-z · 2016
Predictive value of cardiac magnetic resonance imaging-derived myocardial strain for poor outcomes in patients with acute myocarditis
10.3348/kjr.2017.18.4.643 · 2017
The association of myocardial strain with cardiac magnetic resonance and clinical outcomes in patients with acute myocarditis
10.3389/fcvm.2023.1121083 · 2023
Cardiovascular magnetic resonance in pericardial diseases
10.1186/1532-429x-11-14 · 2009
Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging
10.1093/ehjci/jeab128 · 2022
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches
10.1016/j.jacc.2004.11.069 · 2005
Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols
10.1007/s10554-013-0189-7 · 2013
Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis
10.1161/01.cir.97.18.1802 · 1998
MRI of acute myocarditis: a comprehensive approach based on various imaging sequences
10.1378/chest.122.5.1638 · 2002
Functional and morphological parameters with tissue characterization of cardiovascular magnetic imaging in clinically verified “infarct-like myocarditis”
2016
Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review
10.1186/s12968-016-0308-4 · 2016
T2 mapping in myocardial disease: a comprehensive review
10.1186/s12968-022-00866-0 · 2022
10.1186/s12968-017-0389-8
10.1186/s12968-017-0389-8 · 2017
Multiparametric cardiovascular magnetic resonance imaging in acute myocarditis: a comparison of different measurement approaches
10.1186/s12968-019-0568-x · 2019
Diagnostic accuracy of cardiovascular magnetic resonance in acute myocarditis: a systematic review and meta-analysis
10.1016/j.jcmg.2017.12.008 · 2018
Detection and monitoring of acute myocarditis applying quantitative cardiovascular magnetic resonance
10.1161/circimaging.116.005242 · 2017
Performance of t1 and t2 mapping cardiovascular magnetic resonance to detect active myocarditis in patients with recent-onset heart failure
10.1161/circimaging.114.003073 · 2015
Comprehensive cardiac magnetic resonance imaging in patients with suspected myocarditis: the MyoRacer-trial
10.1016/j.jacc.2016.02.013 · 2016
Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis
10.1186/s12968-017-0350-x · 2017
Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis
10.1016/j.jacc.2017.08.050 · 2017
Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis
10.1186/s12968-015-0185-2 · 2015
Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery
10.1016/j.jacc.2012.01.007 · 2012
“Cardiac magnetic resonance” working group of the Italian society of cardiology. Prognostic value of repeating cardiac magnetic resonance in patients with acute myocarditis
10.1016/j.jacc.2019.08.1061 · 2019
Long-term prognostic value of myocardial fibrosis in patients with Chagas cardiomyopathy
10.1016/j.jacc.2018.08.2195 · doi-reference
Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas’ heart disease
10.1590/s0066-782x2012005000031 · doi-reference
Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance
10.1186/s12968-015-0200-7 · doi-reference
Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas’ disease: a marker of disease severity
10.1016/j.jacc.2005.06.067 · doi-reference
Sudden death in Chagas’ disease
10.1590/s0066-782x2001000100008 · doi-reference
Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis
10.1016/j.jcmg.2016.05.009 · doi-reference
Complementary value of cardiac magnetic resonance imaging and positron emission tomography/computed tomography in the assessment of cardiac sarcoidosis
10.1161/circimaging.117.007030 · doi-reference
Myocarditis
10.1056/nejmra0800028 · doi-reference
Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis
10.1016/j.jcmg.2016.11.019 · doi-reference
Cardiac sarcoidosis
10.1016/j.jacc.2016.03.605 · doi-reference
Arrhythmogenic left ventricular cardiomyopathy
10.1136/heartjnl-2020-316944 · doi-reference
Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study
10.1093/ehjci/jez277 · doi-reference
Possible causes and clinical relevance of a “ring-like” late gadolinium enhancement pattern
10.1016/j.jcmg.2023.08.004 · doi-reference
Ring-like late gadolinium enhancement for predicting ventricular tachyarrhythmias in non-ischaemic dilated cardiomyopathy
10.1093/ehjci/jeab117 · doi-reference
Prognostic value of nonischemic ringlike left ventricular scar in patients with apparently idiopathic nonsustained ventricular arrhythmias
10.1161/circulationaha.120.047640 · doi-reference
Myocardial injury pattern at MRI in COVID-19 vaccine-associated myocarditis
10.1148/radiol.212559 · doi-reference
Comparative risk of myocarditis/pericarditis following second doses of BNT162b2 and mRNA-1273 coronavirus vaccines
10.1016/j.jacc.2022.08.799 · doi-reference
Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex
10.1161/circulationaha.122.059970 · doi-reference
Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021
10.1001/jama.2021.24110 · doi-reference
Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel
10.1056/nejmoa2109730 · doi-reference
Myocarditis after Covid-19 vaccination in a large health care organization
10.1056/nejmoa2110737 · doi-reference
10.1016/j.jacc.2022.02.003
10.1016/j.jacc.2022.02.003 · doi-reference
Characteristics of COVID-19 myocarditis with and without multisystem inflammatory syndrome
10.1016/j.amjcard.2021.12.031 · doi-reference
Imaging findings of multisystem inflammatory syndrome in children associated with COVID-19
10.1007/s00247-021-05065-0 · doi-reference
Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19
10.1093/ehjci/jeaa212 · doi-reference
Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID-19
10.1148/radiol.2020202288 · doi-reference
Cardiac magnetic resonance in the evaluation of COVID-19
10.15420/cfr.2021.20 · doi-reference
Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the society for cardiovascular magnetic resonance
10.1186/s12968-023-00933-0 · doi-reference
Cardiovascular magnetic resonance for patients with COVID-19
10.1016/j.jcmg.2021.08.021 · doi-reference
Myocardial injury on CMR in patients with COVID-19 and suspected cardiac involvement
10.1016/j.jcmg.2022.10.021 · doi-reference
Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study
10.1161/circulationaha.120.051828 · doi-reference
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study
10.1093/eurheartj/ehaa664 · doi-reference
Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study
10.1161/circulationaha.122.060632 · doi-reference
Cardiac magnetic resonance findings in patients recovered from COVID-19: initial experiences in elite athletes
10.1016/j.jcmg.2020.11.014 · doi-reference
COVID-19 myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR)
10.1161/circulationaha.120.052573 · doi-reference
Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers
10.1016/j.jcmg.2021.04.011 · doi-reference
T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a cardiovascular magnetic resonance study
10.1186/s12968-021-00764-x · doi-reference
Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)
10.1001/jamacardio.2020.3557 · doi-reference
Diagnosis and treatment of acute myocarditis: a review
10.1001/jama.2023.3371 · doi-reference
2024 ACC expert consensus decision pathway on strategies and criteria for the diagnosis and management of myocarditis
10.1016/j.jacc.2024.10.080 · doi-reference